您的位置：首页 > 产品中心 > 202825-46-5， Safinamide Mesylate
Safinamide Mesylate
| 产品编号： | 4140453 |
| 规格： | Pharmaceutical Secondary Standard; Certified Reference Material |
| CAS NO： | 202825-46-5 |
| 包装规格： | 50 mg |
| 产品类别： | 进口试剂 |
| 品牌： | Supelco |
| 优惠价： | 立即咨询 |
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4140453 | 50 mg | 5950 |
产品别名
202825-46-5
Safinamide Mesylate
Safinamide mesylate salt
(S)-(+)-2-[[4-(3-Fluorobenzoxy)benzyl]amino]propanamide; (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide; FCE-26743; PNU-151774E, NW-1015;
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C17H19FN2O2 · xCH4O3S |
| Molecular weight | 302.34 (free base basis) |
| MDL number | MFCD15145475 |
| General description【一般描述】 | Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards |
| Biochem/physiol Actions【生化/生理作用】 | Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, safinamide is voltage-dependent sodium and calcium channel blocker. It appears to bind to the batrachotoxin-sensitive site 2 of the voltage-sensitive sodium channels. Safinamide blocks N and L-type calcium channels and inhibits glutamate and aspartate release from synaptic terminals. |
| Analysis Note【分析说明】 | These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. |
| Other Notes【其他说明】 | This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. |
| Footnote【附注】 | To see an example of a Certificate of Analysis for this material enter LRAC4350 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. |
产品性质
| grade【等级】 | certified reference material pharmaceutical secondary standard |
| form【形式】 | powder |
| CofA | current certificate can be downloaded |
| packaging【包装】 | pkg of 50 mg |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | CS(O)(=O)=O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O |
| InChI | 1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1 |
| InChI key | YKOCHIUQOBQIAC-YDALLXLXSA-N |
| Gene Information | human ... MAOB(4129) |
安全信息
| Pictograms【象形图】 | GHS07,GHS08 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 - H319 - H361d |
| Precautionary Statements | P202 - P264 - P270 - P301 + P312 - P305 + P351 + P338 - P308 + P313 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
